Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma

Within 5 years after percutaneous ablation of hepatocellular carcinoma, roughly 70% of patients experience tumor recurrence. Relapses beyond curative options affected patients’ survival. Ablation shares with resection common predictive factors of recurrence as size of the tumor, multinodularity and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepat Oncol
Egile Nagusiak: Ganne-Carrié, Nathalie, Nault, Jean-Charles, Ziol, Marianne, N'Kontchou, Gisèle, Nahon, Pierre, Grando, Véronique, Bourcier, Valérie, Barge, Sandrine, Beaugrand, Michel, Trinchet, Jean-Claude, Seror, Olivier
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2014
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6095149/
https://ncbi.nlm.nih.gov/pubmed/30190975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.22
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak